CN109152754A - 用于治疗/预防鼻充血的羧酸 - Google Patents

用于治疗/预防鼻充血的羧酸 Download PDF

Info

Publication number
CN109152754A
CN109152754A CN201780029992.2A CN201780029992A CN109152754A CN 109152754 A CN109152754 A CN 109152754A CN 201780029992 A CN201780029992 A CN 201780029992A CN 109152754 A CN109152754 A CN 109152754A
Authority
CN
China
Prior art keywords
pharmaceutical composition
carboxylic acid
pharmaceutically acceptable
solution
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780029992.2A
Other languages
English (en)
Chinese (zh)
Inventor
B·厄恩斯特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advocate Biotechnology Co Ltd
Original Assignee
Advocate Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advocate Biotechnology Co Ltd filed Critical Advocate Biotechnology Co Ltd
Publication of CN109152754A publication Critical patent/CN109152754A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201780029992.2A 2016-05-17 2017-05-17 用于治疗/预防鼻充血的羧酸 Pending CN109152754A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16169882 2016-05-17
EP16169882.4 2016-05-17
PCT/EP2017/061832 WO2017198702A1 (en) 2016-05-17 2017-05-17 Carboxylic acid for treating/preventing nasal congestion

Publications (1)

Publication Number Publication Date
CN109152754A true CN109152754A (zh) 2019-01-04

Family

ID=56014856

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780029992.2A Pending CN109152754A (zh) 2016-05-17 2017-05-17 用于治疗/预防鼻充血的羧酸

Country Status (13)

Country Link
US (1) US20200000751A1 (https=)
EP (1) EP3458043A1 (https=)
JP (1) JP6975473B2 (https=)
KR (1) KR102430892B1 (https=)
CN (1) CN109152754A (https=)
AU (1) AU2017266726A1 (https=)
BR (1) BR112018072177A2 (https=)
CA (1) CA3020485A1 (https=)
CL (1) CL2018003270A1 (https=)
MX (1) MX2018013475A (https=)
RU (1) RU2018143564A (https=)
SG (2) SG10202006016QA (https=)
WO (1) WO2017198702A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11206245B2 (en) * 2009-10-14 2021-12-21 Trice Imaging, Inc. Systems and devices for encrypting, converting and interacting with medical images
US11948678B2 (en) * 2009-10-14 2024-04-02 Trice Imaging, Inc. Systems and devices for encrypting, converting and interacting with medical images
GB202004690D0 (en) * 2020-03-31 2020-05-13 Edinburgh Napier Univ Composition for enhancing immune response of cells
US12414928B2 (en) 2021-05-14 2025-09-16 Rene Dumalaog Javier Viral inactivation spray and gargling formulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063363A (en) * 1997-05-27 2000-05-16 Goodwin; Gary J Treatment for upper respiratory tract infections with potassium salts
PL193131B1 (pl) * 1997-12-23 2007-01-31 Schering Corp Kompozycja farmaceutyczna zawierająca kombinację składników aktywnych i jej zastosowanie
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
DE10337186A1 (de) * 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
CA2538760A1 (en) * 2003-09-19 2005-03-31 Otsuka Pharmaceutical Co., Ltd. Human .beta.-defensin secretion promoter
US20070256812A1 (en) * 2006-04-19 2007-11-08 Wen-Chen Wei Multidirectional heat dissipating structure
US20070286812A1 (en) * 2006-06-09 2007-12-13 Toutounghi Camille Nasal formulation
ES2748632T3 (es) * 2012-10-03 2020-03-17 Proponent Biotech Gmbh Composición farmacéutica que comprende ácido propiónico para uso en el tratamiento de infecciones víricas

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ROBERT B.TAYLOR: "《全科医学理论与实践 第5版》", 31 October 2003, 华夏出版社 *
森满保: "《图解耳鼻咽喉科学》", 31 December 1998, 海洋出版社 *

Also Published As

Publication number Publication date
SG10202006016QA (en) 2020-07-29
CL2018003270A1 (es) 2019-02-22
KR102430892B1 (ko) 2022-08-09
BR112018072177A2 (pt) 2019-02-12
US20200000751A1 (en) 2020-01-02
RU2018143564A3 (https=) 2020-07-23
CA3020485A1 (en) 2017-11-23
SG11201808322PA (en) 2018-10-30
AU2017266726A1 (en) 2018-10-11
JP2019516797A (ja) 2019-06-20
EP3458043A1 (en) 2019-03-27
WO2017198702A1 (en) 2017-11-23
KR20190009294A (ko) 2019-01-28
JP6975473B2 (ja) 2021-12-01
RU2018143564A (ru) 2020-06-17
MX2018013475A (es) 2019-08-12

Similar Documents

Publication Publication Date Title
JP5863641B2 (ja) 濃縮肥満細胞安定化用薬学的調合物
CN109152754A (zh) 用于治疗/预防鼻充血的羧酸
US20100297034A1 (en) Osmolyte-containing preparation for use in case of dry mucous membranes
TR201807714T4 (tr) İnhalasyon tedavisine yönelik nebülize antibiyotikler.
EA031856B1 (ru) Проглатываемая таблетка n-ацетилцистеина
US20230137840A1 (en) Mint mask and methods of use thereof
HRP20100208T8 (hr) Postupak liječenja akutnog rinosinusitisa
RU2353376C1 (ru) Способ лечения и профилактики бронхопневмонии у телят и поросят
CA2701388C (en) Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
RU2598644C2 (ru) Изопропиловый эфир [(1r,2s,5r)-2-изопропил-5-метилциклогексанкарбонил)-амино]-уксусной кислоты, родственные соединения и их применение в терапии
US20060210482A1 (en) Chemical composition and method for cold and sinus relief
US20170202835A1 (en) Osmolyte-containing preparation for the treatment of dry mucous membranes
HK40002357A (en) Carboxylic acid for treating/preventing nasal congestion
WO2022063320A1 (zh) 一种抑制呼吸道病毒的组合物及呼吸道病毒防治方法
ES2398576T3 (es) Tratamiento agudo de la fobia social con un esteroide androsta-4,16-dien-3-ol
JP2004510783A (ja) 肺感染症および肺腫瘍を治療するためのリポペプチド類およびリポプロテイン類の使用
JP2010260855A (ja) 気道異物除去剤及び気道異物除去用組成物
US11890409B1 (en) Methods of curing early stages of, and preventing, upper respiratory infections and applicators therefor
RU2140273C1 (ru) Способ лечения простудных заболеваний
DAVIS Inhalation of penicillin and streptomycin in office practice
KR20250016360A (ko) 고농도 분자 요오드를 함유하는 급성 호흡기 감염성 질환 예방 및 치료 조성물 및 방법
WO2025146443A1 (en) Antibacterial compositions comprising honey
CN118785913A (zh) 等渗或高渗盐基组合物、治疗、装置以及用于将其递送至喉的制剂
CN105326789A (zh) 氨溴索沙丁胺醇溶液剂
Warren Ozœna and Strumous Disease Treated by Medicated Inhalation—A New Inhaling Apparatus

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40002357

Country of ref document: HK

WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190104

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 40002357

Country of ref document: HK